Detalles de la búsqueda
1.
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study).
Future Oncol
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420911
2.
[Thrombotic microangiopathy with gastrointestinal hemorrhage during carfilzomib therapy for multiple myeloma].
Rinsho Ketsueki
; 64(4): 255-259, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-37121768
3.
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts.
Eur J Haematol
; 109(6): 779-786, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130908
4.
Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
Chemotherapy
; 67(2): 96-101, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839292
5.
[Novel therapies for chronic myeloid leukemia].
Rinsho Ketsueki
; 63(6): 655-659, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35831202
6.
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes.
Cancer Sci
; 111(6): 2132-2145, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304130
7.
Increased Arbekacin Clearance in Patients With Febrile Neutropenia.
Ther Drug Monit
; 42(1): 133-138, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31323015
8.
[Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
Rinsho Ketsueki
; 61(3): 245-250, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-32224585
9.
Combined treatment with benzo[a]pyrene and 1α,25-dihydroxyvitamin D3 induces expression of plasminogen activator inhibitor 1 in monocyte/macrophage-derived cells.
Toxicol Appl Pharmacol
; 345: 48-56, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29524502
10.
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group.
Oncology
; 94(2): 85-91, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29151104
11.
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
Ann Hematol
; 97(11): 2081-2088, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946911
12.
One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
J Infect Chemother
; 24(7): 544-548, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29627326
13.
[Achievement of a stringent complete response with low-dose pomalidomide monotherapy in a multiple myeloma patient].
Rinsho Ketsueki
; 59(4): 395-400, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-29743398
14.
Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study.
Hematol Oncol
; 40(5): 1094-1096, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781821
15.
Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
Cancer Cell Int
; 16: 37, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27182202
16.
Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.
Cancer Cell Int
; 15: 30, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25805962
17.
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.
Am J Hematol
; 90(9): 819-24, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26103598
18.
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
Am J Hematol
; 90(4): 282-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25530131
19.
Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis.
Hematol Oncol
; 37(3): 323-325, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30950076
20.
Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
Ann Hematol
; 93(6): 957-63, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24441947